IMMUNOGENE ZUSAMMENSETZUNG, ENTHALTEND EIN ADJUVANS

Patent europeic · EP1959992 · En vigur

Inscripziun en il register

Numer da publicaziun
EP1959992
Numer da la dumonda
EP06831376
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
12-12-2006
Publitgà
27-08-2008
Concedì
25-01-2012
La protecziun finescha il pli tard
11-12-2026
Proxima taxa annuala scadenta
31-12-2026
Classas IPC
A61K 39/00 (2006.01)
A61K 39/12 (2006.01)
A61K 39/145 (2006.01)
Prioritad
GB 0525321 13.12.2005
GB 0609902 18.05.2006
GB 0620336 12.10.2006
GB 0620337 12.10.2006
Dumonda PCT
PCT/GB2006/004634 12.12.2006
Publicaziun PCT
WO2007/068907 21.06.2007
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-01-2026

    Midada

    Published in Swissreg on 01.01.2026

  2. 01-01-2025

    Midada

    Published in Swissreg on 01.01.2025

  3. 01-01-2024

    Midada

    Published in Swissreg on 01.01.2024

  4. 01-01-2023

    Midada

    Published in Swissreg on 01.01.2023

  5. 09-02-2012

    Represchentant inscrit

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 09.02.2012

  6. 25-01-2012

    Concedì

    Published in Swissreg on 25.01.2012

Partidas

Possessur

GlaxoSmithKline Biologicals S.A.

rue de l'Institut, 89, 1330 Rixensart, BE

Represchentant

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventur

VANDEPAPELIERE, Pierre

B-1330 Rixensart, BE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.